31
Thuries Serge: Noise reduction by image subtraction in an automatic data collection device, such as an image acquisition device. Intermec Ip, Thuries Serge, DE GUZMAN Dennis M, January 18, 2007: WO/2007/009005 (30 worldwide citation)

An automatic data collection device (10) and method reads images from display screen (22) of an electronic display device (24), such as a cellular telephone. The method reads a flashing image of a target machine-readable symbol (12) displayed on the display screen, by obtaining at least two images o ...


32
Gardiner Elisabeth M, Duron Wergio G, Massari Mark E, Severance Daniel L, Semple Joseph E, Smith Nicholas D: Celullar cholesterol absorption modifiers. Kalypsys, Gardiner Elisabeth M, Duron Wergio G, Massari Mark E, Severance Daniel L, Semple Joseph E, Smith Nicholas D, HO Raymond J, January 18, 2007: WO/2007/008529 (30 worldwide citation)

The present invention relates to compounds and methods useful as inhibitors of cholesterol absorption for the treatment or prevention of cholesterol-related diseases, such as atherosclerosis.


33
Mckerrecher Darren, Pike Kurt Gordon, Waring Michael James: 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes. Astrazeneca, Astrazeneca, Mckerrecher Darren, Pike Kurt Gordon, Waring Michael James, GLOBAL INTELLECTUAL PROPERTY, January 18, 2007: WO/2007/007040 (30 worldwide citation)

Compounds of formula (I) wherein R1, HET-1 and HET-2 are as described in the specification, and their salts, are activators of glucokinase (GLK) and are thereby useful in the treatment of, for example, type 2 diabetes. Processes for preparing compounds of formula (I) are also described.


34
Fujito Kenji, Hashimoto Tadao, Nakamura Shuji: Method for growing group iii-nitride crystals in supercritical ammonia using an autoclave. The Regents Of The University Of California, Japan Science and Technology Agency, Fujito Kenji, Hashimoto Tadao, Nakamura Shuji, GATES George H, January 18, 2007: WO/2007/008198 (29 worldwide citation)

A method of growing high-quality, group-III nitride, bulk single crystals. The group III-nitride bulk crystal is grown in an autoclave in supercritical ammonia using a source material or nutrient that is a group III-nitride polycrystals or group-III metal having a grain size of at least 10 microns o ...


35
Doronina Svetlana O, Kline Toni Beth, Jeffrey Scott, Senter Peter D, Meyer Damon: Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus. Seattle Genetics, Doronina Svetlana O, Kline Toni Beth, Jeffrey Scott, Senter Peter D, Meyer Damon, January 18, 2007: WO/2007/008848 (28 worldwide citation)

Auristatin peptide analogs of MeVal-Val-Dil-Dap-Phe (MMAF) having a carboxylic acid equivalent at the C-terminal phenylalanine were prepared and attached to ligands through various linkers, including maleimidocaproyl-val-cit-PAB. The resulting ligand drug conjugates were active in vitro and in vivo.


36
Mckerrecher Darren, Pike Kurt Gordon, Waring Michael James: Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes. Astrazeneca, Astrazeneca, Mckerrecher Darren, Pike Kurt Gordon, Waring Michael James, GLOBAL INTELLECTUAL PROPERTY, January 18, 2007: WO/2007/007041 (28 worldwide citation)

Compounds of formula (I) wherein R1, HET-1 and HET-2 are as described in the specification, and their salts and pro-drugs, are activators of glucokinase (GLK) and are thereby useful in the treatment of, for example, type 2 diabetes. Processes for preparing compounds of formula (I) are also described ...


37
Mckerrecher Darren, Pike Kurt Gordon, Waring Michael James: Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes. Astrazeneca, Astrazeneca, Mckerrecher Darren, Pike Kurt Gordon, Waring Michael James, GLOBAL INTELLECTUAL PROPERTY, January 18, 2007: WO/2007/007042 (28 worldwide citation)

Compounds of formula (I) wherein R1, R2, R3, and HET-1 are as described in the specification, and their salts, are activators of glucokinase (GLK) and are thereby useful in the treatment of, for example, type 2 diabetes. Processes for preparing compounds of formula (I) are also described.


38
Bader Dieter: An optical system with at least a semiconductor light source and a method for removing contaminations and/or heating the systems. Carl Zeiss Smt, Bader Dieter, SAWODNY Michael, January 18, 2007: WO/2007/006447 (28 worldwide citation)

A method for removing contaminations from optical elements or parts thereof, especially from at least one surface of at least one optical element, with UV light, characterized in that at least one semiconductor light source is used for removing the contaminations, wherein said at least one semicondu ...


39
Höffkes Horst, Gross Wibke, Oberkobusch Doris, Knübel Georg: (De) Mittel zum färben und/oder aufhellen keratinischer fasern mit ionischen flüssigkeiten, (En) Ionic-liquid-containing products for dyeing and/or brightening keratin fibres. Henkel Kommanditgesellschaft Auf Aktien, Höffkes Horst, Gross Wibke, Oberkobusch Doris, Knübel Georg, HENKEL KGsA, January 18, 2007: WO/2007/006418 (28 worldwide citation)

(EN) The invention relates to products which are used for dyeing and/or brightening keratin fibres, contain at least from 0.01 to 85 % by weight ionic liquid and from 0 to 5 % by weight water, with respect to the weight thereof, and which exhibit an improved sedimentation behaviour, a good storabili ...


40
Malandain Hugues: Measurement instrument for percutaneous surgery. Kyphon, Malandain Hugues, HUTTER Christopher R, January 18, 2007: WO/2007/008709 (27 worldwide citation)

In one embodiment, an apparatus includes a projection having a tapered end portion (22) configured to be inserted percutaneously through tissue, A measurement member (20) is coupled to the projection and is configured to indicate a distance between adjacent anatomical structures. In another embodime ...